Last reviewed · How we verify
Chinese Herb Astragalus membranaceus
At a glance
| Generic name | Chinese Herb Astragalus membranaceus |
|---|---|
| Sponsor | China Medical University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate the Effect of Elix Cycle Balance and Daily Harmony on Polycystic Ovary Syndrome (NA)
- Effect of SQJZ Herbal Mixtures on Non-motor Symptoms of Parkinson's Disease (PHASE2)
- Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy (PHASE2, PHASE3)
- Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney Disease (PHASE2, PHASE3)
- RSYR for Fatigue Reduction in Cancer Survivors (PHASE2)
- Study on Children Henoch-Schönlein Purpura Nephritis With TCM Multistep Treatment (PHASE1, PHASE2)
- Evaluating the Safety and Efficacy of Qishen Granules Among Patients With Chronic Heart Failure (PHASE2)
- Traditional Chinese Medicine Xiang-sha-liu-jun Granules in Patients With Postprandial Distress Syndrome(PDS) (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: